Kaufmann SH - Search Results

1

A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.

Gojo I, Beumer JH, Pratz KW, McDevitt MA, Baer MR, Blackford AL, Smith BD, Gore SD, Carraway HE, Showel MM, Levis MJ, Dezern AE, Gladstone DE, Ji JJ, Wang L, Kinders RJ, Pouquet M, Ali-Walbi I, Rudek MA, Poh W, Herman JG, Karnitz LM, Kaufmann SH, Chen A, Karp JE. Gojo I, et al. Among authors: kaufmann sh. Clin Cancer Res. 2017 Feb 1;23(3):697-706. doi: 10.1158/1078-0432.CCR-16-0984. Epub 2016 Aug 8. Clin Cancer Res. 2017. PMID: 27503200 Free PMC article. Clinical Trial.

2

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

Rowinsky EK, Grochow LB, Hendricks CB, Ettinger DS, Forastiere AA, Hurowitz LA, McGuire WP, Sartorius SE, Lubejko BG, Kaufmann SH, et al. Rowinsky EK, et al. Among authors: kaufmann sh. J Clin Oncol. 1992 Apr;10(4):647-56. doi: 10.1200/JCO.1992.10.4.647. J Clin Oncol. 1992. PMID: 1312588 Clinical Trial.

3

Expression of nuclear envelope lamins A and C in human myeloid leukemias.

Kaufmann SH. Kaufmann SH. Cancer Res. 1992 May 15;52(10):2847-53. Cancer Res. 1992. PMID: 1581898

4

Topoisomerase II levels during granulocytic maturation in vitro and in vivo.

Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ. Kaufmann SH, et al. Cancer Res. 1991 Jul 1;51(13):3534-43. Cancer Res. 1991. PMID: 1647269

5

Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.

Kaufmann SH. Kaufmann SH. Cancer Res. 1991 Feb 15;51(4):1129-36. Cancer Res. 1991. PMID: 1705167

6

Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.

Kaufmann SH. Kaufmann SH. Cancer Res. 1989 Nov 1;49(21):5870-8. Cancer Res. 1989. PMID: 2790800

7

Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia.

Schneider E, Cowan KH, Bader H, Toomey S, Schwartz GN, Karp JE, Burke PJ, Kaufmann SH. Schneider E, et al. Among authors: kaufmann sh. Blood. 1995 Jan 1;85(1):186-93. Blood. 1995. PMID: 7528566 Free article.

8

Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.

Rowinsky EK, Noe DA, Grochow LB, Sartorious SE, Bowling MK, Chen TL, Lubejko BG, Kaufmann SH, Donehower RC. Rowinsky EK, et al. Among authors: kaufmann sh. J Clin Oncol. 1995 Aug;13(8):1975-84. doi: 10.1200/JCO.1995.13.8.1975. J Clin Oncol. 1995. PMID: 7636538 Clinical Trial.

9

Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo.

Kaufmann SH, Charron M, Burke PJ, Karp JE. Kaufmann SH, et al. Cancer Res. 1995 Mar 15;55(6):1255-60. Cancer Res. 1995. PMID: 7882318

10

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia.

Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ. Kaufmann SH, et al. Blood. 1994 Jan 15;83(2):517-30. Blood. 1994. PMID: 7904487 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,196 results

Search Page